实施基于容量的喂养方案优化重症患者肠内营养输送:一项更新的荟萃分析与系统评价
该更新的荟萃分析与系统评价纳入16项研究共2896例重症患者,比较基于容量的喂养方案与基于速率的喂养方案对肠内营养输送的影响。结果显示,基于容量的喂养方案显著提高能量输送(MD=15.41%,95%CI:10.68至20.14,p<0.00001)和蛋白质输送(MD=22.05%,95%CI:10.89至33.22,p=0.0001),并缩短ICU停留时间(MD=0.78,95%CI:0.01至1.56,p=0.05)。该方案不增加死亡风险(RR=1.03,95%CI:0.85至1.24,p=0.76),不延长机械通气时间(MD=0.81,95%CI:-0.30至1.92,p=0.15),也不影响腹泻、呕吐、喂养不耐受和胃残余量等肠内营养并发症。
要点
- 基于容量的喂养方案较基于速率的喂养方案显著提高能量输送(MD=15.41%,95%CI:10.68至20.14,p<0.00001)和蛋白质输送(MD=22.05%,95%CI:10.89至33.22,p=0.0001)。
- 基于容量的喂养方案不增加死亡风险(RR=1.03,95%CI:0.85至1.24,p=0.76),不延长机械通气时间(MD=0.81,95%CI:-0.30至1.92,p=0.15)。
- 基于容量的喂养方案不增加腹泻(RR=0.91,95%CI:0.73至1.15,p=0.43)、呕吐(RR=1.23,95%CI:0.76至1.99,p=0.41)、喂养不耐受(RR=1.14,95%CI:0.63至2.09,p=0.66)或胃残余量(RR=0.45,95%CI:0.16至1.30,p=0.14)风险。
- 基于容量的喂养方案组ICU停留时间较短(MD=0.78,95%CI:0.01至1.56,p=0.05)。
- 该更新荟萃分析纳入16项研究共2896例重症患者,较前次荟萃分析新增9项研究、2205例患者。
适用人群与场景
- 纳入标准:重症患者(入住ICU的患者)。
- 排除标准:年龄<18岁、重复文献、动物和细胞实验、缺乏纳入标准中任何结局的研究。
研究设计与关键结果
- 研究类型:更新的荟萃分析与系统评价,纳入16项研究共2896例重症患者;较前次荟萃分析新增9项研究、2205例患者。
- 主要结局:基于容量的喂养方案较基于速率的喂养方案显著提高能量输送(MD=15.41%,95%CI:10.68至20.14,p<0.00001)和蛋白质输送(MD=22.05%,95%CI:10.89至33.22,p=0.0001)。
- 次要结局:基于容量的喂养方案组ICU停留时间较短(MD=0.78,95%CI:0.01至1.56,p=0.05);不增加死亡风险(RR=1.03,95%CI:0.85至1.24,p=0.76),不延长机械通气时间(MD=0.81,95%CI:-0.30至1.92,p=0.15)。
- 肠内营养并发症:基于容量的喂养方案不影响腹泻(RR=0.91,95%CI:0.73至1.15,p=0.43)、呕吐(RR=1.23,95%CI:0.76至1.99,p=0.41)、喂养不耐受(RR=1.14,95%CI:0.63至2.09,p=0.66)和胃残余量(RR=0.45,95%CI:0.16至1.30,p=0.14)。
证据类型、等级与局限
- 证据类型:更新的荟萃分析与系统评价。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于容量的喂养方案可能优化重症患者的能量和蛋白质输送,且不增加死亡、机械通气时间或肠内营养并发症风险。
- 该结论基于合并16项研究的荟萃分析,适用于入住ICU的重症患者,年龄<18岁者排除。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aims to provide an updated assessment of the efficacy of optimized enteral nutrition (EN) delivery by implementing the volume-based feeding (VBF) protocol in critically ill patients.
METHODS: We updated our previous literature retrieval with no language restrictions. The inclusion criteria were:1) Participants: Critically ill patients (Patients who was admitted in ICU; 2) Intervention: The VBF protocol was adopted for EN administration; 3) Comparison: The rate-based feeding (RBF) protocol was adopted for EN administration; 4) Major outcomes: EN nutrition delivery. The exclusion criteria included participants aged < 18 years, duplicated literature, animal and cellular experiments, and studies lacking any of the outcomes mentioned in the inclusion criteria. The databases included MEDLINE (through PubMed), Web of Science, Cochrane Library, Chinese Biomedical Literature Service System (SinoMed), Wanfang Data Knowledge Service Platform, and China National Knowledge Infrastructure.
RESULT: Sixteen studies involving a total of 2896 critically ill patients are included in the updated meta-analysis. Compared with the previous meta-analysis, nine new studies were added that included 2205 more patients. The VBF protocol significantly improved energy (MD = 15.41%, 95% CI: [10.68, 20.14], p < 0.00001) and protein (MD = 22.05%, 95% CI: [10.89, 33.22], p = 0.0001) delivery. The patients in the VBF group stayed in the ICU for a shorter time (MD = 0.78, 95% CI: [0.01, 1.56], p = 0.05). The VBF protocol did not increase the risk of death (RR = 1.03, 95% CI: [0.85, 1.24], p = 0.76) or prolong the mechanical ventilation duration (MD = 0.81, 95% CI: [-0.30,1.92], p = 0.15). In addition, the VBF protocol did not affect EN complications, such as diarrhea (RR = 0.91, 95% CI: [0.73, 1.15], p = 0.43), emesis (RR = 1.23, 95% CI: [0.76, 1.99], p = 0.41), feeding intolerance (RR = 1.14, 95% CI: [0.63, 2.09], p = 0.66), and gastric retention (RR = 0.45, 95% CI: [0.16, 1.30], p = 0.14).
CONCLUSION: Our study revealed that the VBF protocol significantly improved calorie and protein delivery in critically ill patients with no additional risk.
参考来源
- Wang L, Wang Y, Li HX, et al. Optimizing enteral nutrition delivery by implementing volume-based feeding protocol for critically ill patients: an updated meta-analysis and systematic review. Crit Care. 2023. PMID: 37147701. doi:10.1186/s13054-023-04439-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。